Streetbeat News

Stock Prices

BURBY

Burberry Group PLC shares rose nearly 4% following an upgrade by Deutsche Bank, which now rates the company as a 'buyer'. The bank anticipates benefits from improved marketing and a focus on core strengths, setting a target price of 1,180p, indicating a potential 32% rise.

Portfolio Pulse from

December 02, 2024 | 1:15 pm

TSLA

Stifel analyst Stephen Gengaro has raised Tesla's stock price target from $287 to $411, maintaining a Buy rating. This has led to a rise in Tesla's stock, exciting Wall Street.

Portfolio Pulse from

December 02, 2024 | 1:15 pm

STLA

Stellantis CEO Carlos Tavares has resigned amid challenges in the U.S. market and declining sales. This leadership change could impact the company's strategic direction and investor confidence.

Portfolio Pulse from

December 02, 2024 | 1:00 pm

TSLA

Elon Musk's plans to cut the U.S. budget have raised concerns about his focus on Tesla. A hedge-fund manager worries that Musk's attention might be diverted from the EV company.

Portfolio Pulse from

December 02, 2024 | 1:00 pm

TSLA

Tesla's stock experiences a rally following the release of an anticipated update to its Full Self-Driving (FSD) software.

Portfolio Pulse from

December 02, 2024 | 1:00 pm

STLA

The Peugeot family, a major shareholder in Stellantis, has expressed its continued support for the company following the unexpected resignation of CEO Carlos Tavares.

Portfolio Pulse from

December 02, 2024 | 1:00 pm

LOW

Lowe's Companies, the second-largest home improvement chain, has generated significant returns over the past 50 years, with a total return of 245,200%. The company reported $83.7 billion in trailing-12-month sales.

Portfolio Pulse from

December 02, 2024 | 1:00 pm

BNO

Oil prices increased as futures rose on Monday, recovering from a volatile November. This rise is attributed to a cease-fire between Israel and Iran-backed Hezbollah, and the anticipation of a postponed OPEC+ meeting.

Portfolio Pulse from

December 02, 2024 | 1:00 pm

AVXL

Anavex Life Sciences Corp. (Nasdaq: AVXL) will participate in the 7th Annual Evercore ISI HealthCONx Conference 2024. CEO Christopher U. Missling will engage in a fireside chat on December 4th, 2024, discussing the company's developments in therapeutics for CNS diseases.

Portfolio Pulse from

December 02, 2024 | 12:45 pm